{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:27:17Z","timestamp":1759692437426},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/jcp.0b013e318297980e","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T11:08:31Z","timestamp":1372331311000},"page":"608-613","source":"Crossref","is-referenced-by-count":13,"title":["Weight Gain in Risperidone Therapy"],"prefix":"10.1097","volume":"33","author":[{"given":"Tulin","family":"Yanik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Kursungoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Sutcigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210128","first-page":"137","article-title":"Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.","volume":"26","author":"Purdon","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2005.07.038","article-title":"One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.","volume":"81","author":"Keefe","year":"2006","journal-title":"Schizophr Res"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1176\/appi.ajp.159.11.1932","article-title":"Inpatient antipsychotic drug use in 1998, 1993, and 1989.","volume":"159","author":"Centorrino","year":"2002","journal-title":"Am J Psychiatr"},{"key":"R4-4-20210128","first-page":"329","article-title":"Noncompliance in schizophrenia.","volume":"4","author":"Babiker","year":"1986","journal-title":"Psychiatr Dev"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","article-title":"Cost of relapse in schizophrenia.","volume":"21","author":"Weiden","year":"1995","journal-title":"Schizophr Bull"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0149-2918(98)80034-9","article-title":"Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety.","volume":"20","author":"Davies","year":"1998","journal-title":"Clin Ther"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance.","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr Res"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/070674370104600308","article-title":"Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.","volume":"46","author":"McIntyre","year":"2001","journal-title":"Can J Psychiatry"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/11596300-000000000-00000","article-title":"Atypical antipsychotic-induced weight gain: insights into mechanisms of action.","volume":"25","author":"Roerig","year":"2011","journal-title":"CNS Drugs"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.","volume":"17","author":"Lett","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4088\/JCP.v62n0404","article-title":"Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.","volume":"62","author":"Basson","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2174\/138945006779025400","article-title":"Susceptibility genes for the side effect of antipsychotics on body weight and obesity.","volume":"12","author":"Chagnon","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.genom.2.1.9","article-title":"Pharmacogenomics: the inherited basis for inter-individual differences in drug response.","volume":"2","author":"Evans","year":"2001","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00213-004-1949-9","article-title":"Pharmacogenetics of antipsychotic induced weight gain.","volume":"174","author":"Correll","year":"2004","journal-title":"Psychopharmacology"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2010.06.001","article-title":"Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin.","volume":"121","author":"Fernandez","year":"2010","journal-title":"Schizophr Res"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms.","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"6","key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/JCP.0b013e3181fae248","article-title":"Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.","volume":"30","author":"Perez-Iglesias","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/14622416.9.8.1055","article-title":"Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from North India: role of metabolic pathway genes.","volume":"9","author":"Srivastava","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pnpbp.2012.03.001","article-title":"Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.","volume":"38","author":"Brandl","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YPG.0b013e3283328e06","article-title":"Leptin gene -2548GA variants predict risperidone-associated weight gain in children and adolescents.","volume":"19","author":"Calarge","year":"2009","journal-title":"Psychiatr Genet"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/JCP.v62n0208","article-title":"Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.","volume":"62","author":"Cohen","year":"2001","journal-title":"J Clin Psych"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00023210-200115070-00004","article-title":"Body weight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.","volume":"15","author":"Russell","year":"2001","journal-title":"CNS Drugs"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.","volume":"156","author":"Kapur","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1097\/00004714-199502001-00004","article-title":"Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.","volume":"15","author":"Farde","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuint.2005.04.020","article-title":"Impact of haloperidol and risperidone on gene expression profile in the rat cortex.","volume":"47","author":"Liliana","year":"2005","journal-title":"Neurochem Int"},{"issue":"suppl 6","key":"R29-4-20210128","first-page":"5","article-title":"Neuro-hormonal control of food intake; basic mechanisms and clinical implications.","volume":"56","author":"Konturek","year":"2005","journal-title":"J Physiol Clin Implications"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/oby.2006.308","article-title":"Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance.","volume":"14","author":"Berthoud","year":"2012","journal-title":"Obesity"},{"issue":"5581","key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine.","volume":"297","author":"Heisler","year":"2002","journal-title":"Science"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.med.52.1.339","article-title":"Effects of neuropeptides and leptin on nutrient partitioning: dysregulations in obesity.","volume":"52","author":"Jeanrenaud","year":"2001","journal-title":"Annu Rev Med"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr Res"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI118254","article-title":"Recombinant ob protein reduces feeding and body weight in the obob mouse.","volume":"96","author":"Weigle","year":"1995","journal-title":"J Clin Invest"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.7624778","article-title":"Mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.","volume":"269","author":"Campfield","year":"1995","journal-title":"Science"},{"issue":"14","key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1097\/00001756-199909290-00029","article-title":"5-HT(2A2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY stimulated eating.","volume":"10","author":"Currie","year":"1999","journal-title":"Neuroreport"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.euroneuro.2012.04.016","article-title":"Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies.","volume":"23","author":"Mas","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psyneuen.2012.06.012","article-title":"The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy.","volume":"33","author":"Ak","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11920-009-0006-0","article-title":"Metabolic risks in older adults receiving second-generation antipsychotic medication.","volume":"11","author":"Brooks","year":"2009","journal-title":"Curr Psychiatry Rep"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.med.54.101601.152403","article-title":"Genetics and pathophysiology of human obesity.","volume":"54","author":"Cummings","year":"2003","journal-title":"Annu Rev Med"},{"issue":"2","key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hup.1097","article-title":"Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment.","volume":"25","author":"Maayan","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"R42-4-20210128","first-page":"458","article-title":"Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdia-lysates from ventral striatum.","volume":"1","author":"Gruber","year":"2006","journal-title":"J Neurosci Res"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0006-3223(99)00239-5","article-title":"Plasma neuropeptide-Y concentrations in humans exposed to military survival training.","volume":"47","author":"Charles","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/phrs.2000.0725","article-title":"New aspects on the melanocortins and their receptors.","volume":"42","author":"Wikberg","year":"2000","journal-title":"Pharmacol Res"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress.","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R46-4-20210128","first-page":"891","article-title":"Can stress cause depression Prog Neuropsychopharmacol Biol Psychiatry.","volume":"28","author":"Van Praag","year":"2004","journal-title":""},{"issue":"2","key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1152\/ajpendo.00516.2009","article-title":"Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density.","volume":"299","author":"Cawley","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrn2493","article-title":"CART peptides: regulators of body weight, reward and other functions.","volume":"10","author":"Rogge","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/diabetes.50.9.2157","article-title":"Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and co-segregating with obesity phenotype in a large family.","volume":"50","author":"Del Giudice","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/en.2005-0812","article-title":"The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans.","volume":"147","author":"Yanik","year":"2006","journal-title":"Endocrinology"},{"key":"R51-4-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/157488906778773616","article-title":"The hypothalamus and obesity.","volume":"3","author":"Harrold","year":"2006","journal-title":"Recent Patents CNS Drug Discov"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318297980e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T17:38:59Z","timestamp":1688319539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201310000-00004"}},"subtitle":["Investigation of Peripheral Hypothalamic Neurohormone Levels in Psychotic Patients"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318297980e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}